To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Completed · Phase 3

Conditions studied: Stress Urinary Incontinence

In brief

The patients are being followed in this study to determine the safety of taking the medication Duloxetine for a long period of time. The patients participating in this study suffer from Stress Urinary Incontinence.

Key facts

Study ID

NCT00190645

Run by

Eli Lilly and Company

People needed

600

Starts

2001-02-01

Expected to finish

2006-05-01

Last updated by the study team

2007-01-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Successfully completed the protocol for Study F1J-MC-SBAV.

You may not qualify if…

• Treatment with a drug, not including study medication, that has not received regulatory approval at the time of study entry.
• Use of excluded medications within 14 days prior to study entry or at any time during the study.

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician — Denver, Colorado, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559,1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician — Oakville, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.